The emergence of peripheral blood progenitor cells to support intensive chemotherapy for patients with breast cancer

Pharmacotherapy

Volumn 16, Issue 3, 1996, Pages 945-1005

  Demetri, George D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGED; BREAST CANCER; CANCER CHEMOTHERAPY; CELL MOTILITY; CELL TRANSPLANTATION; CONFERENCE PAPER; DOSE CALCULATION; FEMALE; HEALTH CARE DELIVERY; HEMATOPOIETIC CELL; HUMAN; MAJOR CLINICAL STUDY; PATIENT CARE; PERIPHERAL LYMPHOCYTE; STEM CELL; THROMBOCYTOPOIESIS;

BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 3142628394     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Demetri GD, Elias AD. Peripheral blood stem cells, progenitor cells, and hematopoietic growth factors: current status of basic scientific knowledge and clinical applications. Adv Oncol 1994;10:11-19.
2. Demetri GD. The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer. Hematol Oncol Clin North Am 1994;8:233-49.
3. Freireich EJ, Levin RH, Whang J, Carbone PP, Bronson W, Morse EE. The function and fate of transfused leukocytes from donors with chronic myelogenous leukemia in leukopenic recipients. Ann NY Acad Sci 1964;113:1081-9.
4. Cavins JA, Scheer SC, Thomas AD, Ferrebee JW. The recovery of lethally irradiated dogs given infusions of autologous leukocytes preserved at -80°C. Blood 1964;23: 38-43.
5. Goldman JR, Thns K, Park D, Spiers A, Lowenthal R, Ruutu T. Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation. Br J Haematol 1978;40:185-95.
6. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man Blood 1976;47: 1031-9.
7. Cline MJ, Golde DW. Endotoxin induces mobilization of hematopoietic progenitors into the blood. Exp Hematol 1977;5:186-90.
8. Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD. Granulocyte-macrophage colony-stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988;2:1194-8.
9. Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988;72:2074-81.
10. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991;77:211-13.
11. Elias AD, Ayash L, Anderson KC, et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992;79:3036-44.
12. Sheridan WP, Begley CG, Juttner CA, et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992;339:640-4.
13. Shea TC, Mason JR, Storniolo AM, et al. Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy. J Clin Oncol 1992;10: 464-73.
14. Goldman J. Editorial: peripheral blood stem cells for allografts. Blood 1995;85:1413-15.